Cellular and molecular mechanisms of metformin: an overview
Open accessThe DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Considerable efforts have been made since the 1950s to better understand the cellular and molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now recommended as the first-line oral therapy for T2D (Type 2 diabetes). The main effect of this drug from the biguanide family is to acutely decrease hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory chain complex I. In addition, the resulting decrease in hepatic energy status activates AMPK (AMP-activated protein kinase), a cellular metabolic sensor, providing a generally accepted mechanism for the action of metformin on hepatic gluconeogenesis. The demonstration that respiratory chain complex I, but not AMPK, is the primary target of metformin was recently strengthened by showing that the metabolic effect of the drug is preserved in liver-specific AMPK-deficient mice. Beyond its effect on glucose metabolism, metformin has been reported to restore ovarian function in PCOS (polycystic ovary syndrome), reduce fatty liver, and to lower microvascular and macrovascular complications associated with T2D. Its use has also recently been suggested as an adjuvant treatment for cancer or gestational diabetes and for the prevention in pre-diabetic populations. These emerging new therapeutic areas for metformin will be reviewed together with recent findings from pharmacogenetic studies linking genetic variations to drug response, a promising new step towards personalized medicine in the treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, metformin reduces insulin resistance and inhibits ovarian androgen production via effects on steroidogenic acute regulatory protein and 17alphahydroxylase (Diamanti-Kandarakis et al. , 2010; Viollet et al. , 2012).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Viollet et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“a drug that is currently being used to treat type II diabetic patients, metformin [74], can activate AMPK”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
In the citing paper
“By far the most important mechanism is the reduction in hepatic glucose production that is considered mediated by the activation of the global energy sensor in cells, adenosine monophosphate-activated protein kinase (AMPK) (Figure 1).(46)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 4×
“Thus, AMPK activation by metformin induces the phosphorylation and inactivation of acetyl CoA carboxylase (ACC), an important rate-controlling enzyme for the synthesis of malonylCoA, which is both a critical precursor for the biosynthesis of fatty acids and a potent inhibitor of mitochondrial fatty acid oxidation [17].”
BackgroundInfluentialHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Furthermore, the authors found a doseresponse relationship between duration of exposure to metformin and cancer incidence [106].”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 25×
“Metformin most likely does not directly activate either LKB1 or AMPK as the drug does not influence the phosphorylation of AMPK by LKB1 in cell-free assay [21].”
BackgroundInfluential
Cited by
Items 901–1,000 of 1,001
Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review)
Han, P., Zhou, J., Xiang, J., Liu, Q., & Sun, K. (2022) · Oncology Reports · doi:10.3892/or.2022.8440 · Cited by 18
Littlejohn, C., Renaud, J. B., Sabourin, L., Lapen, D. R., Pappas, J. J., Tuteja, B., Hughes, D., Ussery, E. J., Yeung, K. K. ‐., & Sumarah, M. W. (2023) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5684 · Cited by 16
Metformin and Cancer in Type 2 Diabetes
Park, H. K. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.2.113 · Cited by 17
Effects of anti-diabetic drugs on bone metabolism
Mabilleau, G., Chappard, D., Flatt, P. R., & Irwin, N. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1077697 · Cited by 17
Metformin Reduces Lipogenesis Markers in Obese Mice Fed a Low‐Carbohydrate and High‐Fat Diet
Santana, K. N. O., Lelis, D. D. F., Mendes, K. L., Lula, J. F., Paraíso, A. F., Andrade, J. M. O., Feltenberger, J. D., Cota, J., da Costa, D. V., de Paula, A. M. B., et al. (2016) · Lipids · doi:10.1007/s11745-016-4209-y · Cited by 17
Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS
Diri, H., Bayram, F., Simsek, Y., Caliskan, Z., & Kocer, D. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.84 · Cited by 19
Metformin abuse: A novel and dangerous purging behavior in anorexia nervosa
Geer, B., Gibson, D., Grayeb, D. E., Benabe, J., Victory, S., Mehler, S., & Mehler, P. S. (2019) · International Journal of Eating Disorders · doi:10.1002/eat.23010 · Cited by 16
The scope of phytotherapy in southern African antidiabetic healthcare
Sabiu, S., Madende, M., Ajao, A. A., Ogundeji, O. A., Lekena, N., & Alayande, K. A. (2019) · Transactions of the Royal Society of South Africa · doi:10.1080/0035919x.2019.1575927 · Cited by 18
Management of Hypertension in the Obese Pregnant Patient
Coroyannakis, C., & Khalil, A. A. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0927-x · Cited by 17
Oliveira, P. W. C., de Sousa, G. J., Birocale, A. M., Gouvêa, S. A., de Figueiredo, S. G., Abreu, G. R., & Bissoli, N. S. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.005 · Cited by 16
Skibitskiy, V. V., Gutova, S. R., Вадимовна, Ф. А., & Витальевич, С. А. (2020) · Kardiologiia · doi:10.18087/cardio.2020.4.n1112 · Cited by 16
Naghiaee, Y., Didehdar, R., Pourrajab, F., Rahmanian, M., Heiranizadeh, N., Mohiti, A., & Mohiti-Ardakani, J. (2020) · Endocrine · doi:10.1007/s12020-020-02459-2 · Cited by 16
Khan, N. M., Ahmad, A., Tiwari, R., Kamal, M. A., Mushtaq, G., & Ashraf, G. M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023160448 · Cited by 20
An MG53-IRS1-interaction disruptor ameliorates insulin resistance
Park, J. S., Lee, H., Choi, B. W., Ro, S., Lee, D., Na, J. E., Hong, J.-H., Lee, J., Kim, B.-W., & Ko, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0099-9 · Cited by 18
From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin
Campagnoli, L. I. M., Varesi, A., Fahmideh, F., Hakimizad, R., Petkovic, P., Barbieri, A., Marchesi, N., & Pascale, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199748 · Cited by 16
Rosidi, B., Priyatno, D., Putra, T. P., & Yusuf, I. (2023) · Cancer Management and Research · doi:10.2147/cmar.s385278 · Cited by 15
Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis
Karimi, F., Dinarvand, N., Sabaghan, M., Azadbakht, O., Ataee, S., Kharazinejad, E., & Moazamfard, M. (2023) · Endocrine · doi:10.1007/s12020-023-03477-6 · Cited by 15
Host-directed therapy against tuberculosis: Concept and recent developments
Udinia, S., Suar, M., & Kumar, D. (2023) · Journal of Biosciences · doi:10.1007/s12038-023-00374-y · Cited by 16
Fawzi, H. A., Hamad, I. N., Kadhim, S. A. A., AL-Temimi, S. M., Mohammad, B. I., & Swadi, A. A. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0317 · Cited by 16
Exercise, exerkines and exercise mimetic drugs: Molecular mechanisms and therapeutics
Samant, V., & Prabhu, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123225 · Cited by 17
Chang, P., Yeh, K., Wang, C., Chen, E. Y., Yang, S., Chou, W., & Hsieh, C. (2017) · Head & Neck · doi:10.1002/hed.24793 · Cited by 15
Metformin reduces risk of varicose veins in patients with type 2 diabetes
Tseng, C. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3206 · Cited by 17
Could metformin be therapeutically useful in Huntington’s disease?
Tang, B. L. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0072 · Cited by 15
In-vitro Synergistic Effect of Metformin and Berberine on High Glucose-induced Lipogenesis.
Khorzoughi, R. B., Namvarjah, F., Teimouri, M., Hosseini, H., & Meshkani, R. (2019) · PubMed Central · doi:10.22037/ijpr.2019.15085.12867 · Cited by 19
Palazzolo, G., Mollica, H., Lusi, V., Rutigliani, M., Francesco, M. D., Pereira, R. C., Filauro, M., Paleari, L., DeCensi, A., & Decuzzi, P. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100760 · Cited by 17
Cytogenetic effects of antidiabetic drug metformin
Yüzbaşıoğlu, D., Mahmoud, J. H., Mamur, S., & Ünal, F. Ş. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1844226 · Cited by 16
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations
Sauvé, M. F., Feldman, F., Koudoufio, M., Ould-Chikh, N.-E.-H., Ahmarani, L., Sané, A. T., Ntimbane, T., El-Jalbout, R., de Serre, N. P., Spahis, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091140 · Cited by 16
Rodent diet aids and the fallacy of caloric restriction
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111584 · Cited by 16
Newsholme, P., Rowlands, J., Rose’Meyer, R. B., & Cruzat, V. F. (2022) · Antioxidants · doi:10.3390/antiox11010108 · Cited by 16
Long, T., Zhang, Y., Zeng, C., Zheng, S., Zhou, L., & Liu, H. (2022) · International Journal of Endocrinology · doi:10.1155/2022/9927240 · Cited by 17
The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
Sanati, M., Aminyavari, S., Mollazadeh, H., Motamed‐Sanaye, A., Bibak, B., Mohtashami, E., Teng, Y., Afshari, A. R., & Sahebkar, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220707103525 · Cited by 15
Unveiling new secrets in Parkinson’s disease: The glycatome
Chegão, A., & Miranda, H. V. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114309 · Cited by 15
Metformin-NSAIDs Molecular Salts: A Path towards Enhanced Oral Bioavailability and Stability
Acebedo-Martínez, F. J., Domínguez‐Martín, A., Alarcón-Payer, C., Garcés-Bastida, C., Verdugo‐Escamilla, C., Gómez‐Morales, J., & Choquesillo‐Lazarte, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020449 · Cited by 15
Promising new pharmacological targets for depression: The search for efficacy
Tsugiyama, L. E., de Moraes, R. C. M., Moraes, Y. A. C., & de Oliveira, J. F. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103804 · Cited by 16
Effect of Low Glycemic Index Diet Versus Metformin on Metabolic Syndrome
Rajabi, S., Mazloom, Z., Zamani, A., & Tabatabaee, H. R. (2015) · Intern J Endocrinol Metab · doi:10.5812/ijem.23091 · Cited by 17
Hans, H., Lone, A., Aksenov, V., & Rollo, C. D. (2015) · AGE · doi:10.1007/s11357-015-9769-x · Cited by 19
Hereditary cancer syndromes as model systems for chemopreventive agent development
Walcott, F. L., Patel, J., Lubet, R. A., Rodriguez, L. M., & Calzone, K. A. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.015 · Cited by 17
Rogalska, A., Forma, E., Bryś, M., Śliwińska, A., & Marczak, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092750 · Cited by 17
Wahdan-Alaswad, R. S., & Thor, A. D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91183 · Cited by 17
A blast from the past: To tame time with metformin
Xenos, D., Mecocci, P., & Boccardi, V. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111743 · Cited by 16
Regulatory functional territory of PLK-1 and their substrates beyond mitosis
Kumar, S., Sharma, G., Chakraborty, C., Sharma, A. R., & Kim, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16290 · Cited by 17
Patton, L., Reverdito, V., Bellucci, A., Bortolon, M., Macrelli, A., & Ricolfi, L. (2025) · Clinics and Practice · doi:10.3390/clinpract15070128 · Cited by 15
Chrysin prevents inflammation-coinciding liver steatosis via AMPK signalling
Gao, C., Zhang, H., Nie, L., He, K., Li, P., Wang, X., Zhang, Z., Xie, Y., Li, S., Liu, G., et al. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad041 · Cited by 14
Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease
Roberts, C.-T., Raabe, N., Wiegand, L., Shahib, A. K., & Rastegar, M. (2024) · Pharmaceuticals · doi:10.3390/ph17121601 · Cited by 14
Park, J. H., Jung, K. H., Jia, D., Yang, S., Attri, K. S., Ahn, S., Murthy, D., Samanta, T., Dutta, D., Ghidey, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101941 · Cited by 20
Linagliptin plus metformin: a pharmacokinetic and pharmacodynamic evaluation
Scheen, A. J. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.767892 · Cited by 17
Prevention of colorectal adenomas
Principi, M., & DeCensi, A. (2014) · Colorectal Disease · doi:10.1111/codi.12817 · Cited by 15
Pioglitazone improves insulin sensitivity and reduces weight loss in Walker-256 tumor-bearing rats
Silva, F. D. F., Ortiz‐Silva, M., Galia, W. B. D. S., Cassolla, P., Graciano, M. F. R., Zaia, C. T. B. V., Zaia, D. A. M., Carpinelli, Â. R., da Silva, F. G., & de Souza, H. M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.12.016 · Cited by 16
Zheng, G., Shen, Z., Xu, A., Jiang, K., Wu, P., Yang, X. D., Chen, X., & Shao, J. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04378 · Cited by 15
Zeng, X., Xu, C., Cheng, J., Sun, C., Wang, Z., Gong, Z., Long, H., & Zhu, B. (2019) · Cancer Medicine · doi:10.1002/cam4.2750 · Cited by 14
Cossu, V., Bauckneht, M., Bruno, S., Orengo, A. M., Emionite, L., Balza, E., Castellani, P., Piccioli, P., Miceli, A., Raffa, S., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100752 · Cited by 15
Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review
Hedayati, N., Oskouei, Z., Tabeshpour, J., & Naeini, M. B. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174590 · Cited by 14
Wu, X., Xiao, X., Chen, X., Yang, M., Hu, Z., Shuai, S., Fu, Q., Yang, H., & Du, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.948101 · Cited by 16
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1
Salatino, A., Mirabelli, M., CHIEFARI, E. D., Greco, M., Vito, A. D., Bonapace, G., Brunetti, F. S., Crocerossa, F., Epstein, A. L., FOTI, D. P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051988 · Cited by 14
Kenkre, J. S., Tan, T., & Bloom, S. R. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.5 · Cited by 17
Cooper, A. C., Fleming, I. N., Phyu, S. M., & Smith, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1909-2 · Cited by 15
Kim, M., Kim, S.-H., Park, S., Sung, M. J., Park, J., Hwang, J., Yang, H. J., Kim, S., Seo, D.-B., Shin, S. S., et al. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.05.050 · Cited by 14
Pandya, K. G., Clark, G. J., & Lau‐Cam, C. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1079-2_32 · Cited by 14
Tomášová, P., Bugáňová, M., Pelantová, H., Holubová, M., Šedivá, B., Železná, B., Haluzík, M., Maletínská, L., Kuneš, J., & Kuzma, M. (2018) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-018-2899-8 · Cited by 14
Drug-drug interactions when treating HIV-related metabolic disorders
Gutiérrez, M. D. M., Mateo, G. M., Corbacho, N., Vidal, F., & Domingo, P. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1667334 · Cited by 14
Calpain inhibition decreases myocardial fibrosis in chronically ischemic hypercholesterolemic swine
Potz, B. A., Sabe, A. A., Sabe, S. A., Lawandy, I. J., Abid, M. R., Clements, R., & Sellke, F. W. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.11.150 · Cited by 14
Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
Tseng, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.587666 · Cited by 14
Ruan, Y., Li, X., You, L., Chen, J., Shen, Y., Zhang, J., Yuan, Y., Kang, L., Qin, C., & Wu, C. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01104 · Cited by 15
Dang, K., Hui, Y.-N., & Du, H. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.08.20 · Cited by 15
AMPK activators for the prevention and treatment of neurodegenerative diseases
Neumann, N. R., Thompson, D. C., & Vasiliou, V. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1991308 · Cited by 15
Safiah, M., Hyassat, D., Khader, Y. S., Farahid, O., Batieha, A. M., El-Khateeb, M. S., & Ajlouni, K. M. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8275303 · Cited by 17
Yang, Q., Wang, G., Fang, D., Gao, X., Yu, L., Wang, L., Wu, J., Zeng, M., & Luo, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113130 · Cited by 14
Vogt, J. A., Wachter, U. A., Wagner, K., Calzia, E., Gröger, M., Weber, S., Stahl, B., Georgieff, M., Asfar, P., Fontaine, E. M., et al. (2014) · Intensive Care Medicine Experimental · doi:10.1186/2197-425x-2-19 · Cited by 17
Mokhtare, B., Çetin, M., Özakar, R. S., & Bayrakçeken, H. (2017) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v16i2.5 · Cited by 14
The Dual Role of Metformin: Repurposing an Antidiabetic Drug for Cancer Therapy
Barbosa, F., Cunha, A., Barbosa, J., Faria, J., & Queirós, O. (2025) · Applied Sciences · doi:10.3390/app152111576 · Cited by 13
Myung, S., Park, Y. Y., & Kim, M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136040 · Cited by 13
Synergistic effect of metformin and EGFR-TKI in the treatment of non-small cell lung cancer
Wang, H., Yang, X. L., Sun, Y., Li, Y., Dong, Y., Shan, D., & Yu, Z. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.11.09 · Cited by 15
Crocker, C. L., Baumgarner, B. L., & Kinsey, S. T. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09568-0 · Cited by 13
Zahra, M. H., Afify, S. M., Hassan, G., Nawara, H. M., Kumon, K., Seno, A., & Seno, M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3661 · Cited by 14
Blackwell, B. R., Ankley, G. T., Biales, A. D., Cavallin, J. E., Cole, A. R., Collette, T. W., Ekman, D. R., Hofer, R. N., Huang, W., Jensen, K. M., et al. (2022) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5450 · Cited by 13
VanGenderen, C. A., Granet, J. A., Filippelli, R. L., Liu, Y., & Chang, N. C. (2022) · Current Protocols · doi:10.1002/cpz1.565 · Cited by 13
Tumour, whole‐blood, plasma and tissue concentrations of metformin in lung cancer patients
Phillips, J. D., Pooler, D. B., Ness, D. B., Fay, K. A., Tau, S. S., Demidenko, E., Hampsch, R. A., Lewis, L. D., & Miller, T. W. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15546 · Cited by 14
Kim, J., Bae, Y., & Kang, H. (2022) · Korean Journal of Family Medicine · doi:10.4082/kjfm.22.0005 · Cited by 13
Uddin, R., Nur-E-Habiba, Rena, G., Hwu, E., & Boisen, A. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00384 · Cited by 13
Liu, J., Tang, M., Zhou, Y., Long, Y., Cheng, Y. Z., & Zheng, H. (2020) · RSC Advances · doi:10.1039/c9ra09923a · Cited by 13
LOTFY, H. M., Elshahed, M. S., & Mohamed, D. (2020) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2020.118551 · Cited by 13
Chew, G. M., Padua, A. J., Chow, D. C., Souza, S. A., Clements, D. M., Corley, M. J., Pang, A. P. S., Alejandria, M. M., Gerschenson, M., Shikuma, C. M., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0172 · Cited by 13
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells
Congiu, T., Alghrably, M., Emwas, A.-H. M., Jaremko, Ł., Lachowicz, J. I., Piludu, M., Piras, M., Faa, G., Pichiri, G., Jaremko, M., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060830 · Cited by 17
de Oliveira, J. S., Silva, A. A. D. N., Dias, F. C. R., de Oliveira, E. L., Filho, E. F. D. O., Soares, P. C., Ferreira, C. M. D. O., & da Silva, V. A. (2022) · International Journal of Experimental Pathology · doi:10.1111/iep.12446 · Cited by 16
Metformin and Pancreatic Cancer Metabolism
Cantoria, M. J., Patel, H., Boros, L. G., & Meuillet, E. J. (2014) · InTech eBooks · doi:10.5772/57432 · Cited by 14
Hasanvand, A., Amini-Khoei, H., Jahanabadi, S., Hadian, M. R., Abdollahi, A., Tavangar, S. M., Mehr, S. E., & Dehpour, A. R. (2017) · Journal of Nephropathology · doi:10.15171/jnp.2018.11 · Cited by 14
Sebaiy, M. M., El-Adl, S. M., Baraka, M. M., & Hassan, A. A. (2018) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2018.4394.1388 · Cited by 13
Moreira, J. D. V., Schwartz, L. H., & Jolicœur, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.573399 · Cited by 13
Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M. A., Rahman, F. I., Mohamed, I. N., & Reza, M. S. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s432790 · Cited by 15
Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights
Papadakos, S. P., Argyrou, A., Lekakis, V., Arvanitakis, K., Kalisperati, P., Stergiou, I. Ε., Konstantinidis, I., Schizas, D., Koufakis, T., Germanidis, G. S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052978 · Cited by 12
Hajimohammadebrahim‐Ketabforoush, M., Zali, A., Shahmohammadi, M., & Hamidieh, A. A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1455492 · Cited by 12
Klaper, R. D., & Niemuth, N. J. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.08.048 · Cited by 12
Islam, T., Rahman, M. S., Paul, N., Akhteruzzaman, S., & Sajib, A. A. (2018) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000493584 · Cited by 12
Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice
Asai, A., Shuto, Y., Nagao, M., Kawahara, M., Miyazawa, T., Sugihara, H., & Oikawa, S. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48223 · Cited by 15
Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus
Tseng, C. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0133 · Cited by 12
Mansourian, M., Karimi, R., & Vaseghi, G. (2018) · EXCLI journal · doi:10.17179/excli2017-993 · Cited by 14
Ramisetti, M., Atmakuri, L. R., Venkata, B. R. M., & Adireddy, V. (2019) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.53.3s.107 · Cited by 12
Cao, Y., Sun, W., & Xu, G. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1659831 · Cited by 12
The chemistry of biguanides: from synthetic routes to applications in organic chemistry
Fortun, S., & Schmitzer, A. R. (2019) · Canadian Journal of Chemistry · doi:10.1139/cjc-2019-0371 · Cited by 12
Mudali, D., Jeevanandam, J., & Danquah, M. K. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1789062 · Cited by 12
Metadata
- Authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F.
- Affiliations
- INSERM, U1016, Institut Cochin, Paris, France
- Leiden University Medical Center (NL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Leclerc, Jocelyne
- Foretz, Marc
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-11-11
- Volume
- 122
- Issue
- 6
- Pages
- 253-270
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3398862
- OpenAlex
- W2154024784
- Cited by
- 1,720
- References
- 167
- Citations by year
- 2026: 63 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 106 · 2021: 143 · 2020: 155 · 2019: 135 · 2018: 141 · 2017: 156 · 2016: 137 · 2015: 144 · 2014: 117 · 2013: 104 · 2012: 34
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, biguanides, AMPK, mitochondrial complex I inhibition, hepatic gluconeogenesis, hepatic glucose production, polycystic ovary syndrome, hepatic steatosis, diabetes complications, adjuvant cancer therapy, gestational diabetes mellitus, prediabetes, pharmacogenetics, personalized medicine
- MeSH terms
- Animals, Cardiovascular System, Diabetic Nephropathies, Female, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Polycystic Ovary Syndrome, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.